Hydroxychloroquine in Hospitalized Patients with COVID ‐19: Real‐World Experience Assessing Mortality
ConclusionsWe report from a large retrospective multinational database analysis of COVID ‐19 outcomes with HCQ and overall mortality in hospitalized patients. There was no statistically significant increase in mortality and mortality‐arrhythmia with HCQ or HCQ‐AZ.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Frank H. Annie,
Cristian Sirbu,
Keely R. Frazier,
Mike Broce,
B. Daniel Lucas Tags: Original Research Article Source Type: research
More News: Arrhythmia | Azithromycin | Clinical Trials | Coronavirus | COVID-19 | Databases & Libraries | Drugs & Pharmacology | Hydroxychloroquine | Statistics | Study | Zithromax